Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

Ahead of print

doi: 10.17219/acem/216746

Publication type: meta-analysis

Thematic category: Gastroenterology; surgery

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Łosińska J, Lewandowski M, Kawiński A, Dziki AJ, Mik M. Risk factors for postoperative complications in Crohn’s disease: A systematic review and meta-analysis [published online as ahead of print on March 30, 2026]. Adv Clin Exp Med. 2026. doi:10.17219/acem/216746

Risk factors for postoperative complications in Crohn’s disease: A systematic review and meta-analysis

Joanna Łosińska1,A,B,C,D,E,F, Miłosz Lewandowski2,C,D,E,F, Andrzej Kawiński2,C,D,E,F, Adam Janusz Dziki2,C,D,E,F, Michał Mik2,A,B,C,D,E,F

1 Department of General Surgery, Chojnice Specialist Hospital, Poland

2 Department of General and Colorectal Surgery, Medical University of Lodz, Military Medical Academy Memorial Teaching Hospital – Central Veterans’ Hospital, Poland

Graphical abstract


Graphical abstracts

Highlights


• Meta-analysis of 51 studies identifies key risk factors for early postoperative complications in Crohn’s disease patients undergoing abdominal surgery.
• Previous surgeries, longer disease duration, Montreal B3 behavior, and L2 location significantly increase the risk of postoperative complications in Crohn’s disease.
• Montreal classification subtypes L1 and B2 are associated with a reduced risk of early surgical and medical complications after Crohn’s disease surgery.
• Findings emphasize the importance of disease phenotype and progression in surgical risk stratification and treatment planning for Crohn’s disease.

Abstract

Background. Crohn’s disease (CD) is a non-specific inflammatory bowel disorder for which no definitive cure is available. The primary management strategy is pharmacological treatment aimed at alleviating symptoms. However, many patients ultimately require surgical intervention to manage complications arising from the disease.

Objectives. The aim of this study was to investigate disease-related factors that may increase the risk of early postoperative complications in patients with CD.

Materials and methods. A meta-analysis was conducted based on studies examining early surgical and medical complications following abdominal surgery for CD. The analyzed risk factors included disease duration prior to surgery, history of previous surgeries, presence of concurrent perianal disease, intra-abdominal abscess during surgery, and Montreal classification subtypes A1–3, L1–4, and B1–3. A systematic review was performed using 4 major databases: PubMed, Cochrane Library, Academic Search Ultimate (EBSCO), and Google Scholar. Outcomes were assessed using the odds ratio (OR) and response ratio (R), together with 95% confidence intervals (95% CIs). Egger’s test was used to evaluate publication bias. Heterogeneity was assessed using the I2 statistic, with I2 > 50% indicating significant variability.

Results. A total of 51 articles met the inclusion criteria. The analysis identified several significant risk-increasing factors: history of previous surgeries (OR = 1.39; 95% CI: 1.23–1.57), Montreal classification group B3 (OR = 1.26; 95% CI: 1.11–1.42), disease duration before surgery (R = 1.10; 95% CI: 1.02–1.18), and group L2 (OR = 1.38; 95% CI: 1.11–1.72). Conversely, factors associated with a reduced risk of postoperative complications included group L1 (OR = 0.81; 95% CI: 0.71–0.92) and group B2 (OR = 0.81; 95% CI: 0.71–0.91).

Conclusions. This meta-analysis aggregated data from a broad spectrum of patients and treatment settings across multiple institutions worldwide. Although some risk of bias and heterogeneity was observed, the findings nevertheless highlight the importance of considering disease subtype and progression when assessing the likelihood of postoperative complications in patients with CD. This knowledge may be valuable for optimizing treatment strategies.

Key words: Crohn’s disease, postoperative complications, risk factors, abdominal surgery, disease progression

Introduction

Crohn’s disease (CD) is classified as a non-specific inflammatory bowel disease characterized by transmural inflammation of the gastrointestinal tract that may occur in any segment, from the mouth to the anus. As the exact etiology of the disease remains unknown, no definitive cure is currently available.1 The primary approach to managing CD involves pharmacological treatment aimed at alleviating symptoms. Nevertheless, many patients ultimately require surgical intervention, including major intra-abdominal procedures such as adhesiolysis, resection of the small or large intestine, strictureplasty, or drainage of intra-abdominal abscesses, to manage complications arising from the disease.

Although CD can affect any segment of the gastrointestinal tract, it most commonly involves the ileocecal region. Inflammation may lead to intestinal strictures and adhesions in some cases, whereas in others it may result in fistulas or intra-abdominal abscesses. Many patients also develop perianal abscesses and fistulas, which present additional clinical challenges. This heterogeneity of disease presentation is reflected in the Montreal classification system, which evaluates the following parameters: age at disease onset, disease location, and disease behavior. The Montreal classification was first introduced at the World Congress of Gastroenterology in Montreal in 2005.2

Research suggests that the severity of CD may be influenced by its specific subtype.3, 4, 5 Indicators such as perianal manifestations, early age at diagnosis, and the ileocolonic subtype may be associated with a more severe disease course.6, 7 Severe disease courses are often accompanied by chronic inflammation, significant malnutrition, and deficiencies in energy and protein, as well as the need for long-term steroid therapy, all of which are recognized risk factors for postoperative complications. Factors associated with a complicated disease course may therefore contribute to an increased risk of unfavorable postoperative outcomes.8

Objectives

When considering treatment options, it is essential to evaluate the likelihood of complications. The aim of this study was to investigate disease-related factors that may influence the risk of early postoperative complications.

Materials and methods

This paper forms part of the research conducted for the doctoral thesis of one of the authors, entitled “Multifaceted Assessment of Perioperative Risk Factors in Patients with Crohn’s Disease (CD).” The findings presented in this study adhere to the guidelines established in the MOOSE (Meta-analysis of Observational Studies in Epidemiology) and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 statements.

Information sources and search strategy

The first author (J.Ł.) conducted a systematic literature search using the PubMed, Cochrane Library, Academic Search Ultimate (EBSCO), and Google Scholar databases between November 21 and December 4, 2021. The search included the following terms: “Crohn’s disease,” “Crohn’s disorder,” “IBD,” “regional enteritis,” combined with “complications,” “outcomes,” “morbidity,” “recurrence,” “relapse,” “remission,” “treatment outcome,” “treatment failure,” and “reoperation,” as well as “postoperative,” “perioperative,” “risk factors,” “contributing factors,” “predisposing factors,” “surgery,” and “resection”. Different combinations of these terms were used with the logical operators “AND” and “OR”. The search included articles published up to December 4, 2021. The authors did not contact researchers to obtain unpublished studies. On July 15, 2025, the databases were re-examined after a 3.5-year interval using the same search strategy to update the literature review. Articles published in all languages were considered. To broaden the search results, the “related articles” function in PubMed and the reference lists of the included studies were also screened.

Eligibility criteria

The selection of articles for the meta-analysis was guided by the PICO framework. Participants: Patients aged >15 years, regardless of race or sex, undergoing abdominal surgery for CD. Intervention: Disease-related risk factors, including disease duration prior to surgery, history of previous surgical procedures, presence of concomitant perianal disease, intra-abdominal abscess during surgery, and disease subtypes A1–3, L1–4, and B1–3 according to the Montreal classification (Table 1). Comparator: Presence vs absence of specific risk factors. Outcome: All complications occurring within 30 days after surgery, as defined by the ACS-NSQIP.9 (Table 2)

Complications were stratified into 5 severity grades (1–5) according to the Clavien–Dindo classification system (Table 3). Articles were included in the analysis if they met the following criteria: reported exact event numbers, provided odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs), reported mean values for the analyzed risk factor in the complication group, and included identifiable corresponding data for the control group. The following study designs were eligible for inclusion: observational studies, randomized controlled trials (RCTs), non-randomized controlled trials, prospective cohort studies, retrospective cohort studies, case–control studies, and cross-sectional studies.

Studies were excluded if they contained insufficient data or represented duplicate publications involving the same group of patients. In addition, studies involving animals, pregnant patients, or individuals diagnosed with indeterminate colitis or ulcerative colitis were excluded. Studies were also excluded if they focused on procedures such as cholecystectomy, organ transplantation, or surgeries related to perianal disease. Furthermore, studies with a follow-up period shorter than 30 days, unclear follow-up duration, or lacking outcome data for a comparison group were excluded from the analysis.

Data collection process

The primary author used Mendeley Desktop v. 1.19.8 (Mendeley Ltd., London, UK) and Microsoft Excel 2010 (v. 14.0.7268.5000; Microsoft Corp., Redmond, USA) to review the selected studies. The extracted data included the study title, authors, year of publication, study design, country of origin, type and date of surgical procedures performed, as well as postoperative complications and their associated risk factors. Any discrepancies were resolved through discussion with the 5th author (M.M.), who served as the principal investigator. Articles written in languages other than English were translated using Google Translate (Google LLC, Mountain View, USA).

Quality assessment

The quality of the included studies was assessed by the first author (J.Ł.) using the Newcastle–Ottawa Scale (NOS). Studies with a score of ≥5 points were considered to be of high quality.

Statistical analyses

Statistical analyses for the meta-analysis were performed using Statistica v. 13.1 (StatSoft Inc., Tulsa, USA). Given the anticipated heterogeneity among studies, a random-effects model was applied. All statistical tests were two-tailed, and p < 0.05 was considered statistically significant. The results were presented in forest plots illustrating 2 effect measures. Odds ratios were calculated for dichotomous outcomes and presented with 95% CIs. Continuous variables, expressed as means with standard deviations (SDs), were analyzed using the response ratio (R), defined as the ratio of the mean value in the treatment group to that in the control group, together with 95% CIs. A chronological cumulative analysis was performed to evaluate how the cumulative effect estimate and its standard error (SE) changed over time with each successive publication. Statistical heterogeneity among studies was assessed using the I2 statistic, with values >50% indicating substantial heterogeneity. Publication bias was assessed using Egger’s test, with p < 0.1 considered indicative of significant asymmetry, and the results were visualized using funnel plots. Sensitivity analyses were conducted to evaluate the influence of individual studies on the pooled effect estimates by sequentially excluding each study from the analysis.

Evaluation of the strength of evidence

The strength of evidence was determined based on 3 criteria, as previously described.10 These criteria included Egger’s test p ≥ 0.1, a total study population exceeding 1,000 patients, and I2 < 50%. Level I strength of evidence (high quality) was assigned when all 3 criteria were satisfied; level II (moderate quality) when 2 criteria were met; level III (moderate quality) when 1 criterion was met; and level IV (low quality) when none of the criteria were fulfilled.

Results

A comprehensive literature search identified a total of 5,157 publications. Of these, 51 articles met the inclusion criteria and were included in the meta-analysis. A detailed overview of the number of records identified, screened, excluded, and included in the analysis is presented in Figure 1. Detailed characteristics of the included studies, together with their quality assessments using the NOS, are presented in Table 4.11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61 No randomized controlled trials were identified; therefore, the meta-analysis was based on cohort studies comprising data from 21,283 patients. The mean age of participants across studies ranged from 29 to 46 years.

Considerable heterogeneity was observed among the included studies. Notably, studies conducted by Celentano et al.,14 the Italian Society of Colorectal Surgery (SICCR),15 and Yu et al.25 focused on cohorts of patients aged ≥16 years. In contrast, Wang et al.,11 Tiberi et al.,16 and O’Brien et al.17 exclusively analyzed severe postoperative complications classified as >3a according to the Clavien–Dindo classification. Mege and Michelassi31 assessed postoperative complications based on rates of acute hospital readmissions. In another study, Mege et al.42 included only patients undergoing ileocecal resection with anastomosis and a temporary protective stoma.

Among the patient-related risk factors associated with early postoperative complications and identified with level I strength of evidence were previous surgical interventions (OR = 1.39; 95% CI: 1.23–1.57; p < 0.001), Montreal classification group B3 (OR = 1.26; 95% CI: 1.11–1.42; p < 0.001), and disease duration prior to surgery (R = 1.10; 95% CI: 1.02–1.18; p = 0.01). A factor identified with level II strength of evidence that showed statistical significance was Montreal classification group L2 (OR = 1.38; 95% CI: 1.11–1.72; p = 0.004). Conversely, factors associated with a decreased risk of postoperative complications and identified with level I strength of evidence included Montreal classification group L1 (OR = 0.81; 95% CI: 0.71–0.92; p = 0.001) and group B2 (OR = 0.81; 95% CI: 0.71–0.91; p = 0.001). For other risk factors, including intraoperative intra-abdominal abscess, concomitant perianal disease, and Montreal classification groups A1–A3, L3, L4, and B1, no statistically significant associations were observed. Further details of the analyses are presented in Table 5, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, and Supplementary Fig. 1–8.

Following the initial analysis, an additional analysis of risk factors associated with severe postoperative complications (defined as Clavien–Dindo grade ≥IIIa) was performed. However, the available data were sufficient to analyze only prior surgical interventions, which did not show a statistically significant association (OR = 1.55; 95% CI: 0.82–2.96; p = 0.181).

Discussion

Crohn’s disease is an inflammatory disorder of the gastrointestinal tract that may involve any segment of the digestive system and is often accompanied by extraintestinal manifestations. The etiology of CD is complex and not fully understood, with multiple factors contributing to its development. These include genetic predisposition, such as variants in the NOD2/CARD15 genes,62 autoimmune responses to intestinal bacterial antigens,63 environmental factors including smoking, dietary habits, and stress,64, 65, 66 as well as dysbiosis of the intestinal microbiota.67 A key characteristic of CD is its chronic course, which may lead to various complications related both to the disease itself and to its management, particularly surgical treatment.68

This meta-analysis aimed to identify disease-related risk factors associated with the occurrence of complications after surgery in patients with CD. Disease duration prior to surgical intervention emerged as a statistically significant predictor of early postoperative complications (class I evidence; R = 1.10; 95% CI: 1.02–1.18; p = 0.01).

Previous studies have also demonstrated the association between longer disease duration and postoperative complications. For example, Hossne et al.69 reported that disease duration was a significant risk factor for postoperative complications, a finding similarly observed by Sakurai Kimura et al.22 The available literature further supports the notion that prolonged disease duration is associated with an increased risk of surgical complications.70 This relationship may be explained by the fact that patients with a longer disease course are particularly susceptible to complications resulting from chronic inflammation, malabsorption, and subsequent nutritional deficiencies, all of which may impair the healing of surgical wounds and intestinal anastomoses.71 Prolonged inflammation may also contribute to the development of complications requiring additional surgical interventions, such as fistulas or intestinal strictures.23, 68, 69, 71 Moreover, repeat surgical procedures are generally associated with a higher risk of complications due to the compromised quality of abdominal tissues, which makes safe surgical dissection and preparation more challenging.72, 73

Additionally, the presence of Montreal classification group B3 (penetrating disease with fistula formation) was identified as a statistically significant risk factor for postoperative complications (level I evidence; OR = 1.26; 95% CI: 1.11–1.42; p < 0.001). Montreal classification group L2 was also identified as a significant risk factor for postoperative complications in this cohort (OR = 1.38; 95% CI: 1.11–1.72; p = 0.004). However, there is no clear consensus regarding the Montreal classification as a prognostic indicator of disease progression. A study by Tajra et al.74 found no association between disease progression as defined by the Montreal classification and the risk of postoperative complications. Conversely, Lin et al.75 suggested that categorizing patients based on colonic involvement may provide a more reliable predictor of clinical outcomes than the Montreal classification. This issue warrants further investigation, particularly in light of reports suggesting that the Montreal classification may be associated with a statistically significant increase in the need for emergency surgical interventions.74

In our study, Montreal classification groups L1 (OR = 0.81; 95% CI: 0.71–0.92; p = 0.001) and B2 (OR = 0.81; 95% CI: 0.71–0.91; p = 0.001) were associated with a reduced risk of postoperative complications. Historically, it has been suggested that patients presenting with stricturing disease experience a milder clinical course both before and after surgery compared with those with penetrating disease manifestations such as fistulas and abscesses, although the supporting evidence remains limited. The Montreal classification for CD reflects this assumption by assigning the most severe disease behavior category to fistulizing (penetrating) disease regardless of the presence of strictures. Patients are classified as having stricturing disease only when strictures occur in isolation. Consequently, the Montreal classification may underestimate the true prevalence of strictures. One proposed mechanism suggests that fistulas and abscesses develop at sites where transmural bowel inflammation coincides with increased intraluminal pressure in intestinal segments proximal to a stricture.76

Another variable identified in this analysis as a statistically significant risk factor for postoperative complications was a history of prior surgical interventions (level I evidence; OR = 1.39; 95% CI: 1.23–1.57; p < 0.001). Patients with a long disease duration and a history of previous surgical procedures represent a distinct subgroup that poses particular challenges in surgical management.70 This observation is supported by the findings of Kotze et al.,70 who reported that a longer interval between the diagnosis of CD and surgical intervention is significantly associated with an increased risk of postoperative complications. Each subsequent surgical procedure may lead to the formation of intra-abdominal adhesions,77 which in patients with CD may be particularly extensive and technically challenging during surgery.70, 78 Clinicians involved in the surgical management of inflammatory bowel disease are well aware that extensive adhesions substantially increase the risk of intraoperative full-thickness intestinal injury.77, 78 This represents a significant challenge, as the surgical management of CD should aim to avoid unnecessary intestinal resections whenever possible.70, 78

The analysis of risk factors such as intraoperative intra-abdominal abscess, perianal involvement, and selected Montreal classification categories (A1–A3, L3, L4, and B1) did not demonstrate statistically significant associations with postoperative complications. In contrast, Bechara et al.79 reported that factors including ileocecal disease location, the presence of fistulas, and perianal disease involvement (L3B3p) were associated with an increased risk of surgical recurrence of CD.79

A possible explanation for the lack of statistical significance observed for the aforementioned Montreal classification categories may be the considerable variability in disease progression associated with these phenotypes. In a study by Tajra et al.,74 the presence of strictures in the jejunum and ileum, perianal lesions in patients with CD, and age at diagnosis were reported to be significantly associated with an increased likelihood of surgical intervention. However, the authors did not evaluate the risk of postoperative complications.

According to Martinez-Sanchez et al.,80 CD with perianal involvement is associated with a poorer prognosis, particularly in cases with rectal involvement, and is linked to a higher frequency of biological therapy use and hospital admissions, especially among patients with complex perianal disease. However, the study did not demonstrate a corresponding increase in the number of abdominal surgeries in this patient group. Furthermore, the prevalence of biological therapy among patients with perianal disease was higher than among those without perianal involvement (42.8% vs 30.7%). The discrepancy between the findings of the present meta-analysis and those reported in the cited study highlights the need for further investigations involving larger patient cohorts to provide sufficient statistical power for a more comprehensive analysis.

Limitations of the study

Several important limitations of this study should be acknowledged. The primary methodological limitation was that the literature review was conducted by a single researcher, a constraint related to the doctoral nature of the project. To minimize potential errors, the process was supervised by the principal investigator, and all included studies underwent thorough verification. Nevertheless, the inherent risk of subjective bias associated with single-reviewer study selection cannot be excluded. Another methodological limitation was the re-examination and inclusion of additional studies 3.5 years after the initial literature search. Although this approach allowed the meta-analysis database to be updated, it may have introduced additional sources of bias. Furthermore, the aggregated data reflect treatment outcomes from diverse clinical centers, where unmeasured institutional factors may substantially influence therapeutic results. Differences in the interpretation of study endpoints across centers may further affect the reliability of the presented findings.

Conclusions

In summary, the findings of the present meta-analysis indicate that prolonged disease duration, penetrating disease behavior with fistula formation (Montreal classification group B3), and a history of prior surgical interventions are significant risk factors associated with an increased likelihood of postoperative complications in patients with CD. Further investigation of factors influencing surgical complications remains warranted. Future studies, particularly prospective investigations as well as those examining immunological, microbial, and genetic determinants, may help refine the identification of predictors of postoperative outcomes in this patient population. Addressing these challenges may play an important role in optimizing surgical management and reducing the risk of postoperative complications. In particular, a better understanding of the effects of chronic inflammation and the impact of gastroenterological therapies on postoperative healing – especially with regard to intestinal anastomoses – may facilitate the identification of more precise predictors of postoperative recovery. Ultimately, this may support the development of clinically applicable predictive models, enabling more personalized treatment strategies and improving patient outcomes and quality of life.

Supplementary data

The supplementary materials are available at https://doi.org/10.5281/zenodo.18467011. The package contains the following files:

Supplementary Fig. 1. Meta-analysis of early postoperative complications for intraoperative abscess.

Supplementary Fig. 2. Meta-analysis of early postoperative complications for concomitant perianal disease.

Supplementary Fig. 3. Meta-analysis of early postoperative complications for Montreal classification group A1.

Supplementary Fig. 4. Meta-analysis of early postoperative complications for Montreal classification group A2.

Supplementary Fig. 5. Meta-analysis of early postoperative complications for Montreal classification group A3.

Supplementary Fig. 6. Meta-analysis of early postoperative complications for Montreal classification group L3.

Supplementary Fig. 7. Meta-analysis of early postoperative complications for Montreal classification group L4.

Supplementary Fig. 8. Meta-analysis of early postoperative complications for Montreal classification group B1.

Use of AI and AI-assisted technologies

Not applicable.

Tables


Table 1. Montreal classification

Clinical factors

Classification

Age at diagnosis [years]

A1, ≤16

A2, 17–39

A3, ≤40

Location

L1, ileal

L2, colonic

L3, ileocolonic

L4, isolated upper gastrointestinal tract disease

Behavior

B1, non-stricturing, non-penetrating

B2, stricturing

B3, penetrating

p, perianal disease

Table 2. Types of complications considered in the study (according to American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) definitions)

Surgical

Medical/clinical

Surgical site infection, wound dehiscence, anastomotic leak, enterocutaneous fistula, intra-abdominal abscess, generalized sepsis, septic shock, postoperative bowel obstruction, unplanned reoperation, peristomy complications, hemorrhage, hematoma, need for blood transfusion.

Dehydration, fever of unknown origin, urinary tract infection, Clostridioides difficile infection, respiratory complications (unplanned intubation, pneumonia, pulmonary edema, pleural effusion, failure to extubate), urinary complications (acute renal failure, progression of chronic kidney disease), cardiovascular complications (pulmonary embolism, acute coronary syndrome, myocardial infarction, cardiac arrhythmias), neurological complications (stroke, psychotic disorders), venous thrombosis, adrenal insufficiency, liver insufficiency, and death.

Table 3. Clavien–Dindo classification

Grade

Definition

I

Any deviation from the normal postoperative course without the need for pharmacological, surgical, endoscopic, or radiological intervention

II

Deviation from the normal postoperative course requiring pharmacological treatment

IIIa

Complication requiring surgical, endoscopic, or radiological intervention not under general anesthesia

IIIb

Complication requiring surgical, endoscopic, or radiological intervention under general anesthesia

IVa

Life-threatening complication requiring intensive care unit (ICU) management with single-organ failure

IVb

Life-threatening complication requiring ICU management with multiple organ failure

V

Death of the patient

Table 4. The articles included in the meta-analysis

Study

Study period

Country/region

Study design

Number of patients

Mean/median* age

Number of complications

Surgery types

NOS scorea

Wang et al., 202411

2017–2022

China

retrospective analysis

181

39.04

10

ICR;

right hemicolectomy;

left-sided colectomy;

subtotal colectomy;

segmental resection of small bowel

5

Lahes et al., 202212

2001–2018

Germany

retrospective analysis

426

41*

158

small bowel or colorectal resection; ileostomy or colostomy; closure of ileostomy or colostomy;

strictureplasty

6

Carmichael et al., 202113

2013–2019

USA

retrospective review of a prospectively maintained database

474

33*

73

ICR

7

Celentano et al., 202114

2018–2019

Italy

retrospective, multicenter, observational study

427

42

87

ileocaecal resection

6

SICCR, 202015

2018–2019

Italy

retrospective, multicenter, snapshot study

122

no information

48

subtotal colectomy: 55; segmental colectomy: 30; proctectomy: 25

7

Tiberi et al., 202016

2008–2019

Italy

observational retrospective study

133

41.2

6

ICR

5

O’Brien et al., 202017

2014–2018

USA

single-institution retrospective observational study

118

40*

19

ICR

5

Kline et al., 202018

2008–2018

USA

retrospective clinical and genetic cohort study

269

no information

86

ileocolectomy

7

Gklavas et al., 202019

2010–2018

Greece

single-center retrospective study

153

36*

35

ICR

7

Dong et al., 202020

2016–2019

China

retrospective review

202

36.5

66

intestinal resection

7

Duan et al., 202021

2016–2019

China

retrospective review

129

no information

55

small-bowel resection: 45; ICR: 44; segmental colectomy: 21; other (ostomy closure, strictureplasty, and stoma creation without resection): 19

6

Sakurai Kimura et al., 202022

2012–2018

Brazil

retrospective review

103

40.6

33

abdominal surgeries for CD

5

Yoon et al., 202023

2005–2015

USA, South Korea

retrospective review

409

35

166

laparoscopic ICR

7

Abdalla et al., 201924

2013–2015

France

prospective multicenter study

567

no information

165

ICR

6

Yu et al., 201925

2006–2015

South Korea

retrospective study

817

no information

204

small bowel surgery: 252; ileocecal resection with or without small bowel surgery: 247; right hemicolectomy with or without small bowel resection: 178; total colectomy with or without small bowel surgery: 66; total proctocolectomy with or without small bowel surgery: 35; left hemicolectomy/anterior resection or low anterior resection with or without small bowel surgery: 18; abdominoperineal resection or Hartmann’s procedure: 21

7

Gutierrez et al., 201926

2007–2010

Spain

retrospective review

364

38

100

ICR with ileocolic anastomosis

6

Bouquot et al., 201927

1998–2016

France

retrospective review

524

no information

186

ICR

6

Müller et al., 201828

2000–2014

Austria

retrospective cohort study

182

31.57

41

laparoscopic intestinal resection: an ileocoecal resection: 123 colonic resections: 46; segmental small bowel resection: 10; rectal resection: 3

7

Aaltonen et al., 201829

2011–2015

Finland

retrospective study

70

41.5*

14

ICR 51; ICR and small bowel resection: 3; small bowel resection: 6; sigmoidectomy with colorectal anastomosis: 3; subtotal colectomy with ileosigmoidal anastomosis: 1; colectomy with ileorectal anastomosis: 6

6

Jouvin et al., 201830

2002–2013

France, Ireland

retrospective review

360

33

87

all ICR with additional: small bowel resection: 31; small bowel suture: 8; strictureplasty: 6; colonic resection: 18; colonic suture: 36; bladder suture: 7; other: 36

6

Mege and Michelassi, 201831

2004–2016

USA

retrospective review of prospectively maintained database

712

no information

70

strictureplasty: 137, stoma-related procedure: 62; small-bowel resection: 616; ileocecal resection: 388; segmental colectomy: 66; proctectomy: 64; extensive resection: 93; other: 72

5

Atasoy et al., 201832

2001–2016

Turkey

retrospective review

147

36

26

ileocecal resection: 105; small bowel resection: 13; colectomy: 29

6

Zhao et al., 201833

2013–2016

China

single-center, retrospective study

186

no information

87

total colectomy: 22; segmental colectomy: 45; ileocecal resection: 47; small bowel resection: 72

6

de Buck van Overstraeten et al., 201734

1998–2013

Belgium, the Netherlands

cohort analysis

538

31*

121

ileocecal resection

7

Kotze et al., 201635

2007–2014

Brazil

retrospective and observational study

123

no information

45

small bowel resection: 39; ileocecal resection: 59; total colectomy: 7

7

Li et al., 201636

1998–2014

USA

retrospective review of prospectively maintained database

1,331

41.2

628

small-bowel resection: 186; ICR: 687; segmental colectomy: 51; total/subtotal colectomy: 192; total proctocolectomy: 134; stoma creation without resection: 52; other (redo ileocolonic anastomosis, strictureplasty, ileostomy revision): 159

7

Zhou et al., 201637

2012–2014

China

retrospective review

73

36.14

25

intestinal resection and anastomoses, with or without a covering stoma

7

Yamamoto et al., 201638

2008–2013

Japan, Italy, Brazil

international multicenter retrospective review

231

33

55

all ICR with primary anastomosis

7

Kristo et al., 201639

1997–2012

Austria

retrospective review

234

no information

39

type of resection – ileocolic: 192; small bowel: 28; colonic: 45; rectal: 1

6

Ding et al., 201540

2011–2013

USA

retrospective review

164

no information

64

stoma-related: 69; small-bowel resection: 20; ICR: 113; partial colectomy: 9; subtotal colectomy: 15; total colectomy: 11; anterior resection: 2

6

Kulaylat et al., 201541

2005–2012

USA

multicenter retrospective review

7,631

41.8

2,099

enterectomy: 1,091; ileocolectomy: 3,190;

partial colectomy: 1,915;

total abdominal proctocolectomy: 1076; proctectomy: 359

7

Mege et al., 201542

2000–2012

France

retrospective review

80

33.5*

15

fecal diversions: 80; covering loop ileostomies: 17; lateral stapling of the sigmoid colon for enterocolonic fistula: 9; left hemi-colectomy for an extended inflammatory mass: 3; complementary small bowel resection: 1; urinary diversion with double J catheter to identify the ureter in an inflammatory mass: 1; liver biopsy for cirrhosis suspicion: 1; no stricturoplasties were performed

5

Scarpa et al., 201543

2000–2013

Italy

retrospective observational review

146

no information

21

total colectomy: 12; ileal resection: 20; colonic resection: 26; ICR: 87; ileal stricturoplasty: 15

7

Connelly et al., 201444

2007–2012

USA

retrospective review

143

no information

41

ileocolectomy

5

Myrelid et al., 201445

no information

Sweden, UK, Spain, Norway, Denmark

retrospective review

298

no information

92

small bowel resection: 36; ICR: 185; colonic resection: 43; stoma closure: 29; strictureplasty alone: 5; including strictureplasty: 20; including severe adhesiolysis: 54

6

Bobanga et al., 201446

2004–2013

USA

retrospective review

142

39

51

ileocecectomy or right hemicolectomy

5

Bellolio et al., 201347

1990–2010

Canada

retrospective review

434

no information

53

ICR

6

Bafford et al., 201348

1999–2010

USA

retrospective review of prospectively maintained database

196

40.9

45

ICR: 127; small bowel resection: 26; segmental colectomy: 13; low anterior resection: 18; protective stomas: 12

6

Huang et al., 201249

2005–2010

USA

retrospective descriptive study

130

no information

26

small bowel resection: 17, ICR: 78, partial colectomie: 20, total abdominal colectomie: 22, other bowel cases: 23

6

Riss et al., 201250

1998–2008

Austria

retrospective review

182

no information

25

ICR: 153; small bowel resection: 25; rectal resection: 2; colonic resection: 24; closure of bowel fistula: 32; strictureplasty: 16; others: 8

5

Yang et al., 201251

1991–2010

South Korea

retrospective review of a prospective database

350

29

81

abdominal surgery

6

Pinto et al., 201152

2001–2008

USA

retrospective analysis based on a prospectively collected database

130

no information

49

ICR: 74; ileocolectomy with other procedure: 25; total abdominal colectomy: 12; extended right colectomy: 8; proctocolectomy: 3; left colectomy: 2; low anterior resection: 2

6

Brouquet et al., 201053

1998–2008

France

retrospective, observational study of a prospective database

61

41*

23

ICR: 54; small bowel resection: 7

7

Holubar et al., 201054

1997–2008

USA

retrospective review of a prospective database

92

41

31

laparoscopic-assisted and hand-assisted laparoscopic surgery;

proctocolectomy with or without anastomosis or stoma;

total abdominal colectomy with or without anastomosis or stoma;

subtotal colectomy with or without anastomosis or stoma; segmental colectomy

7

Nasir et al., 201055

2005–2008

USA

retrospective review of prospectively maintained database

370

41.7

106

ileocecectomy: 104; right hemicolectomy: 49;

transverse colectomy: 3; left hemicolectomy 4;

sigmoid colectomy: 19; subtotal colectomy with ileorectostomy: 14; stricturoplasty: 28; stoma reversal: 37; other: 17

6

Bergamaschi et al., 200956

1992–2006

USA, France

retrospective review

80

40*

6

all ICR with intracorporeal anastomosis

7

Sampietro et al., 200957

1993–2007

Italy, UK

retrospective review

393

39.7

22

In 393 consecutive patients with small bowel CD, a total of 865 jejunoileal segments were treated by using 318 minimal bowel resections and 367 strictureplasties.

5

Takahashi-Monroy, 200558

1979–1997

Mexico

retrospective review

34

46

11

ileocecal resection: 17; total colectomy with ileorectal anastomosis: 5; intestinal resection: 4; left hemicolectomy: 3; total colectomy with Hartmann pouch: 2; total non-restorative proctocolectomy: 2; primary perforation closure: 1

5

Post et al., 199159

1981–1989

Germany

retrospective review of prospectively maintained database

368

33.1

46

gastroenterostomy: 4; jejunal resection: 11; ileal resection: 83; strictureplasty: 70; ileocecal resection/right hemicolectomy: 212; resection of previous anastomosis: 51; colic resection: 99; proctectomy/proctocolectomy: 3; closure of ileostomy/colostomy; closure of enteric fistula: 66; closure of vesical/genital fistula: 29; other: 28

5

Heimann et al., 198560

1978–1983

USA

retrospective study of prospectively maintained database

130

no information

39

ICR: 88; a subtotal colectomy: 21;

abdominoperineal resection of the rectum: 10; small bowel resection only: 11;

either temporary loop ileostomy or a permanent Brooke-type ileostomy: 45

5

Lindor et al. 198561

1982

USA

retrospective review

124

33*

16

bowel resections: 116;

bowel bypass procedures: 5; resection of diseased bowel in combination with bowel bypass: 3

5

NOS – Newcastle–Ottawa Scale; ICR – ileocolic resection.
Table 5. Disease-related risk factors

Risk factor

Number of patients

OR (95%CI) for dichotomous variables

R (95% CI) for continuous variables

p-value

I2

Egger’s test (p-value)

Evaluation of the strength of evidence (level)

Previous surgery

9,939

OR = 1.39 (1.23–1.57)

<0.001

19.74%

0.119

I

Group B3 (according to Montreal classification)

7,982

OR = 1.26 (1.11–1.42)

<0.001

16.32%

0.418

I

Disease duration before surgery

3,485

R = 1.10 (1.02–1.18)

0.01

11.31%

0.489

I

Group L2

5,956

OR = 1.38 (1.11–1.72)

0.004

35.62%

0.002

II

Group L1

5,954

OR = 0.81 (0.71–0.92)

0.001

<0.01%

0.26

I

Group B2

6,586

OR = 0.81 (0.71–0.91)

0.001

<0.01%

0.543

I

Intraoperative abscess

5,055

OR = 0.99 (0.84–1.18)

0.952

4.34%

0.709

Concomitant perianal disease

4,420

OR = 1.26 (0.98–1.62)

0.074

49.17%

0.424

Group A1

1,988

OR = 0.84 (0.61–1.16)

0.279

<0.01%

0.426

Group A2

2,010

OR = 1.1 (0.81–1.5)

0.549

33.74%

0.629

Group A3

2,403

OR = 0.99 (0.7–1.41)

0.959

30.89%

0.311

Group L3

5,422

OR = 1.12 (0.99–1.27)

0.061

<0.01%

0.056

Group L4

2,699

OR = 0.94 (0.61–1.48)

0.8

32.80%

0.636

Group B1

5,744

OR = 0.96 (0.81–1.14)

0.659

<0.01%

0.827

OR – odds ratio; 95% CI – 95% confidence interval; R – response ratio.

Figures


Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 flow diagram
Fig. 2. Meta-analysis of early postoperative complications associated with previous surgery
OR – odds ratio; 95% CI – 95% confidence interval.
Fig. 3. Meta-analysis of early postoperative complications associated with Montreal classification group B3
OR – odds ratio; 95% CI – 95% confidence interval.
Fig. 4. Meta-analysis of early postoperative complications associated with disease duration prior to surgery
OR – odds ratio; 95% CI – 95% confidence interval.
Fig. 5. Meta-analysis of early postoperative complications associated with Montreal classification group L2
OR – odds ratio; 95% CI – 95% confidence interval.
Fig. 6. Meta-analysis of early postoperative complications associated with Montreal classification group L1
OR – odds ratio; 95% CI – 95% confidence interval.
Fig. 7. Meta-analysis of early postoperative complications associated with Montreal classification group B2
OR – odds ratio; 95% CI – 95% confidence interval.

References (80)

  1. Roda G, Chien Ng S, Kotze PG, et al. Crohn’s disease. Nat Rev Dis Primers. 2020;6(1):22. doi:10.1038/s41572-020-0156-2
  2. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut. 2006;55(6):749–753. doi:10.1136/gut.2005.082909
  3. Torres UDS, Rodrigues JO, Junqueira MSG, Uezato S, Netinho JG. The Montreal classification for Crohn’s disease: Clinical application to a Brazilian single-center cohort of 90 consecutive patients. Arq Gastroenterol. 2010;47(3):279–284. doi:10.1590/S0004-28032010000300013
  4. Xiang J, Li J, Liu C, Tian S, Dong W. Clinical features of Crohn’s disease stratified by age at diagnosis according to Montreal classification. J Inflamm Res. 2023;16:737–746. doi:10.2147/JIR.S397483
  5. Halligan S, Boone D, Archer L, et al. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: A systematic review. Health Technol Assess. 2021;25(45):1–66. doi:10.3310/hta25450
  6. Veloso FT. Clinical predictors of Crohn’s disease course. Eur J Gastroeneterol Hepatol. 2016;28(10):1122–1125. doi:10.1097/MEG.0000000000000698
  7. Arieira C, Cúrdia Gonçaves T, Dias De Castro F, João Moreira M, Cotter J. Clinical course in Crohn’s disease: Factors associated with behaviour change and surgery. Scand J Gastroenterol. 2018;53(10–11):1222–1227. doi:10.1080/00365521.2018.1503709
  8. Zhongcheng L, Qingfan Y, Xiuling F, et al. A multicenter case-control study on postoperative intestinal fistula in Chinese patients with Crohn disease. Medicine (Baltimore). 2023;102(49):e36159. doi:10.1097/MD.0000000000036159
  9. Cohen ME, Bilimoria KY, Ko CY, Lee Hall B. Development of an American College of Surgeons National Surgery Quality Improvement Program: Morbidity and Mortality Risk Calculator for Colorectal Surgery. J Am Coll Surg. 2009;208(6):1009–1016. doi:10.1016/j.jamcollsurg.2009.01.043
  10. Mei Z, Wang Q, Zhang Y, et al. Risk factors for recurrence after anal fistula surgery: A meta-analysis. Int J Surg. 2019;69:153–164. doi:10.1016/j.ijsu.2019.08.003
  11. Wang FT, Lin Y, Yuan XQ, et al. Predicting short-term major postoperative complications in intestinal resection for Crohn’s disease: A machine learning-based study. World J Gastrointest Surg. 2024;16(3):717–730. doi:10.4240/wjgs.v16.i3.717
  12. Lahes S, Fischer C, Spiliotis AE, et al. Effect of immunosuppressive medication on postoperative complications following abdominal surgery in Crohn’s disease patients. Int J Colorectal Dis. 2022;37(12):2535–2542. doi:10.1007/s00384-022-04287-4
  13. Carmichael H, Peyser D, Baratta VM, et al. The role of laparoscopic surgery in repeat ileocolic resection for Crohn’s disease. Colorectal Dis. 2021;23(8):2075–2084. doi:10.1111/codi.15675
  14. Celentano V, Pellino G, Spinelli A, et al. Anastomosis configuration and technique following ileocaecal resection for Crohn’s disease: A multicentre study. Updates Surg. 2021;73(1):149–156. doi:10.1007/s13304-020-00918-z
  15. SICCR Current status of Crohn’s disease surgery collaborative; Celentano V, Pellino G, Rottoli M, et al. Surgical treatment of colonic Crohn’s disease: A national snapshot study. Langenbecks Arch Surg. 2021;406(4):1165–1172. doi:10.1007/s00423-020-02038-z
  16. Tiberi A, Pesi B, Giudici F, et al. Laparoscopic ileo-colic resection and right hemicolectomy for Crohn’s disease and colon cancer: A preliminary comparative study on post-operative outcome. Updates Surg. 2020;72(3):821–826. doi:10.1007/s13304-020-00769-8
  17. O’Brien SJ, Chen RC, Stephen VT, et al. Preoperative opioid prescription is associated with major complications in patients with Crohn’s disease undergoing elective ileocolic resection. Dis Colon Rectum. 2020;63(8):1090–1101. doi:10.1097/DCR.0000000000001571
  18. Kline BP, Weaver T, Brinton DL, et al. Clinical and genetic factors associated with complications after Crohn’s ileocolectomy. Dis Colon Rectum. 2020;63(3):357–364. doi:10.1097/DCR.0000000000001574
  19. Gklavas A, Poulaki A, Dellaportas D, Papaconstantinou I. Risk factors for postoperative complications after elective ileocolic resection for Crohn’s disease: A retrospective study. Ann Gastroenterol. 2020;33(6):645–655. doi:10.20524/aog.2020.0533
  20. Dong X, Tang S, Liu W, et al. Prognostic significance of the Controlling Nutritional Status (CONUT) score in predicting postoperative complications in patients with Crohn’s disease. Sci Rep. 2020;10(1):19040. doi:10.1038/s41598-020-76115-0
  21. Duan Y, Liu Y, Li Y. Previous intestinal resection is associated with postoperative complications in Crohn’s disease: A cohort study. Gastroenterol Res Pract. 2020;2020:2194382. doi:10.1155/2020/2194382
  22. Sakurai Kimura CM, Scanavini Neto A, Queiroz NSF, et al. Abdominal surgery in Crohn’s disease: Risk factors for complications. Inflamm Intest Dis. 2021;6(1):18–24. doi:10.1159/000510999
  23. Yoon YS, Stocchi L, Holubar S, et al. When should we add a diverting loop ileostomy to laparoscopic ileocolic resection for primary Crohn’s disease? Surg Endosc. 2021;35(6):2543–2557. doi:10.1007/s00464-020-07670-w
  24. Abdalla S, Brouquet A, Maggiori L, et al. Postoperative morbidity after iterative ileocolonic resection for Crohn’s disease: Should we be worried? A prospective multicentric cohort study of the GETAID Chirurgie. J Crohns Colitis. 2019;13(12):1510–1517. doi:10.1093/ecco-jcc/jjz091
  25. Yu CS, Jung SW, Lee JL, et al. The influence of preoperative medications on postoperative complications in patients after intestinal surgery for Crohn’s disease. Inflamm Bowel Dis. 2019;25(9):1559–1568. doi:10.1093/ibd/izz010
  26. Gutiérrez A, Rivero M, Martín-Arranz MD, et al. Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: Analysis from the PRACTICROHN study. Gastroenterol Rep (Oxf). 2019;7(3):168–175. doi:10.1093/gastro/goz010
  27. Bouquot M, Maggiori L, Hain E, Prost A La Denise J, Bouhnik Y, Panis Y. What is the outcome for patients undergoing more than two ileocolonic resections for recurrent Crohn’s disease? A comparative study of 569 consecutive procedures. Colorectal Dis. 2019;21(5):563–569. doi:10.1111/codi.14562
  28. Müller C, Stift A, Argeny S, et al. Delta albumin is a better prognostic marker for complications following laparoscopic intestinal resection for Crohn’s disease than albumin alone: A retrospective cohort study. PLoS One. 2018;13(11):e0206911. doi:10.1371/journal.pone.0206911
  29. Aaltonen G, Ristimäki A, Keränen I, Carpelan-Holmström M, Lepistö A. Does a histologically inflamed resection margin increase postoperative complications in patients with Crohn’s disease? Scand J Gastroenterol. 2018;53(3):279–283. doi:10.1080/00365521.2018.1435717
  30. Jouvin I, Lefevre JH, Creavin B, et al. Postoperative morbidity risks following ileocolic resection for Crohn’s disease treated with anti-TNF alpha therapy: A retrospective study of 360 patients. Inflamm Bowel Dis. 2018;24(2):422–432. doi:10.1093/ibd/izx036
  31. Mege D, Michelassi F. Readmission after abdominal surgery for Crohn’s disease: Identification of high-risk patients. J Gastrointest Surg. 2018;22(9):1585–1592. doi:10.1007/s11605-018-3805-y
  32. Atasoy D, Aghayeva A, Bilgin İA, Erzin Y, Erenler Bayraktar I, Baca B. Predictive parameters of early postoperative complications in Crohn’s disease: Single team experience. Turk J Gastroenterol. 2018;29(4):406–410. doi:10.5152/tjg.2018.17687
  33. Zhao C, Ding C, Xie T, et al. Validation and optimization of the Systemic Inflammation-Based modified Glasgow Prognostic Score in predicting postoperative outcome of inflammatory bowel disease: Preliminary data. Sci Rep. 2018;8(1):747. doi:10.1038/s41598-017-18771-3
  34. de Buck van Overstraeten A, Eshuis EJ, Vermeire S, et al. Short- and medium-term outcomes following primary ileocaecal resection for Crohn’s disease in two specialist centres. Br J Surg. 2017;104(12):1713–1722. doi:10.1002/bjs.10595
  35. Kotze PG, Saab MP, Saab B, et al. Tumor necrosis factor alpha inhibitors did not influence postoperative morbidity after elective surgical resections in Crohn’s disease. Dig Dis Sci. 2017;62(2):456–464. doi:10.1007/s10620-016-4400-2
  36. Li Y, Stocchi L, Cherla D, Liu X, Remzi FH. Association of preoperative narcotic use with postoperative complications and prolonged length of hospital stay in patients with Crohn disease. JAMA Surg. 2016;151(8):726. doi:10.1001/jamasurg.2015.5558
  37. Zhou W, Cao Q, Qi W, et al. Prognostic nutritional index predicts short-term postoperative outcomes after bowel resection for Crohn’s disease. Nutr Clin Pract. 2017;32(1):92–97. doi:10.1177/0884533616661844
  38. Yamamoto T, Spinelli A, Suzuki Y, et al. Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. United European Gastroenterol J. 2016;4(6):784–793. doi:10.1177/2050640615600116
  39. Kristo I, Stift A, Argeny S, Mittlböck M, Riss S. Minimal-invasive approach for penetrating Crohn’s disease is not associated with increased complications. Surg Endosc. 2016;30(12):5239–5244. doi:10.1007/s00464-016-4871-4
  40. Ding Z, Wu XR., Remer EM, et al. Association between high visceral fat area and postoperative complications in patients with Crohn’s disease following primary surgery. Colorectal Dis. 2016;18(2):163–172. doi:10.1111/codi.13128
  41. Kulaylat AN, Hollenbeak CS, Sangster W, Stewart Sr DB. Impact of smoking on the surgical outcome of Crohn’s disease: A propensity-score matched National Surgical Quality Improvement Program analysis. Colorectal Dis. 2015;17(10):891–902. doi:10.1111/codi.12958
  42. Mege D, Bege T, Beyer-Berjot L, et al. Does faecal diversion prevent morbidity after ileocecal resection for Crohn’s disease? Retrospective series of 80 cases. ANZ J Surg. 2017;87(9):E74–E79. doi:10.1111/ans.13034
  43. Scarpa M, Martinato M, Bertin E, et al. Intestinal surgery for Crohn’s disease: Role of preoperative therapy in postoperative outcome. Dig Surg. 2015;32(4):243–250. doi:10.1159/000381885
  44. Connelly TM, Juza RM, Sangster W, Sehgal R, Tappouni RF, Messaris E. Volumetric fat ratio and not body mass index is predictive of ileocolectomy outcomes in Crohn’s disease patients. Dig Surg. 2014;31(3):219–224. doi:10.1159/000365359
  45. Myrelid P, Marti-Gallostra M, Ashraf S, et al. Complications in surgery for Crohn’s disease after preoperative antitumour necrosis factor therapy. Br J Surg. 2014;101(5):539–545. doi:10.1002/bjs.9439
  46. Bobanga ID, Bai S, Swanson MA, et al. Factors influencing disease recurrence after ileocolic resection in adult and pediatric onset Crohn’s disease. Am J Surg. 2014;208(4):591–596. doi:10.1016/j.amjsurg.2014.06.008
  47. Bellolio F, Cohen Z, MacRae HM, et al. Outcomes following surgery for perforating Crohn’s disease. Br J Surg. 2013;100(10):1344–1348. doi:10.1002/bjs.9212
  48. Bafford AC, Powers S, Ha C, et al. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn’s disease. J Clin Gastroenterol. 2013;47(6):491–495. doi:10.1097/MCG.0b013e3182677003
  49. Huang R, Valerian BT, Lee EC. Laparoscopic approach in patients with recurrent Crohn’s disease. Am Surg. 2012;78(5):595–599. doi:10.1177/000313481207800543
  50. Riss S, Bittermann C, Schwameis K, et al. Determinants for postoperative complications after laparoscopic intestinal resection for Crohn’s disease. Surg Endosc. 2012;26(4):933–938. doi:10.1007/s00464-011-1970-0
  51. Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Risk factors for complications after bowel surgery in Korean patients with Crohn’s disease. J Korean Surg Soc. 2012;83(3):141. doi:10.4174/jkss.2012.83.3.141
  52. Pinto RA, Shawki S, Narita K, Weiss EG, Wexner SD. Laparoscopy for recurrent Crohn’s disease: How do the results compare with the results for primary Crohn’s disease? Colorectal Dis. 2011;13(3):302–307. doi:10.1111/j.1463-1318.2009.02133.x
  53. Brouquet A, Blanc B, Bretagnol F, Valleur P, Bouhnik Y, Panis Y. Surgery for intestinal Crohn’s disease recurrence. Surgery. 2010;148(5):936–946. doi:10.1016/j.surg.2010.02.001
  54. Holubar SD, Dozois EJ, Privitera A, Pemberton JH, Cima RR, Larson DW. Minimally invasive colectomy for Crohn’s colitis: A single institution experience: Inflamm Bowel Dis. 2010;16(11):1940–1946. doi:10.1002/ibd.21265
  55. Nasir BS, Dozois EJ, Cima RR, et al. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn’s disease. J Gastrointest Surg. 2010;14(12):1859–1866. doi:10.1007/s11605-010-1341-5
  56. Bergamaschi R, Haughn C, Reed JF, Arnaud JP. Laparoscopic intracorporeal ileocolic resection for Crohn’s disease: Is it safe? Dis Colon Rectum. 2009;52(4):651–656. doi:10.1007/DCR.0b013e31819ed620
  57. Sampietro GM, Corsi F, Maconi G, et al. Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn’s disease. Clin Gastroenterol Hepatol. 2009;7(2):183–191. doi:10.1016/j.cgh.2008.10.008
  58. Takahashi-Monroy T. Surgical treatment of Crohn’s disease [in Spanish]. Gac Med Mex. 2005;141(5):351–355. PMID:16353879.
  59. Post S, Betzler M, Ditfurth BV, Schürmann G, Küppers P, Herfarth C. Risks of intestinal anastomoses in Crohn’s disease. Ann Surg. 1991;213(1):37–42. doi:10.1097/00000658-199101000-00007
  60. Heimann TM, Greenstein AJ, Mechanic L, Aufses AH. Early complications following surgical treatment for Crohn’s disease. Ann Surg. 1985;201(4):494–498. doi:10.1097/00000658-198504000-00015
  61. Lindor KD, Fleming CR, Ilstrup DM. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn’s disease. Mayo Clin Proc. 1985;60(6):393–396. doi:10.1016/S0025-6196(12)60849-062.
  62. Giudici F, Cavalli T, Luceri C, et al. Long-term follow-up, association between CARD15/NOD2 polymorphisms, and clinical disease behavior in Crohn’s disease surgical patients. Mediators Inflamm. 2021;2021(1):8854916. doi:10.1155/2021/8854916
  63. Lee SH, Turpin W, Espin-Garcia O, et al. Anti-microbial antibody response is associated with future onset of Crohn’s disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk. Gastroenterology. 2021;161(5):1540–1551. doi:10.1053/j.gastro.2021.07.009
  64. Heringer PN, Dias MCBDM, Tecchio JVS, et al. Novas aborgadens nutricionais no manejo das doenças inflamatórias intenstinais. Revista Ibero-Americana de Humanidades, Ciências e Educação. 2023;9(9):119–130. doi:10.51891/rease.v9i9.11155
  65. Sgambato D, Miranda A, Ranaldo R, Federico A, Romano M. The role of stress in inflammatory bowel diseases. Curr Pharm Des. 2017;23(27):3997–4002. doi:10.2174/1381612823666170228123357
  66. Underner M, Perriot J, Cosnes J, Beau P, Peiffer G, Meurice JC. Tabagisme, sevrage tabagique et maladie de Crohn. Presse Med. 2016;45(4):390–402. doi:10.1016/j.lpm.2016.02.008
  67. Caparrós E, Wiest R, Scharl M, et al. Dysbiotic microbiota interactions in Crohn’s disease. Gut Microbes. 2021;13(1):1949096. doi:10.1080/19490976.2021.1949096
  68. Aniwan S, Park SH, Loftus EV. Epidemiology, natural history, and risk stratification of Crohn’s disease. Gastroenterol Clin North Am. 2017;46(3):463–480. doi:10.1016/j.gtc.2017.05.003
  69. Hossne RS, Sassaki LY, Baima JP, Meira Júnior JDD, Campos LM. Analysis of risk actors and postoperative complications in patients with Crohn’s disease. Arq Gastroenterol. 2018;55(3):252–257. doi:10.1590/s0004-2803.201800000-63
  70. Kotze PG, Magro DO, Martinez CAR, et al. Long time from diagnosis to surgery may increase postoperative complication rates in elective CD intestinal resections: An observational study. Gastroenterol Res Pract. 2018;2018:4703281. doi:10.1155/2018/4703281
  71. Ghoneima AS, Flashman K, Dawe V, Baldwin E, Celentano V. High risk of septic complications following surgery for Crohn’s disease in patients with preoperative anaemia, hypoalbuminemia and high CRP. Int J Colorectal Dis. 2019;34(12):2185–2188. doi:10.1007/s00384-019-03427-7
  72. Crowell KT, Messaris E. Risk factors and implications of anastomotic complications after surgery for Crohn’s disease. World J Gastrointest Surg. 2015;7(10):237. doi:10.4240/wjgs.v7.i10.237
  73. Cima R, Wolff B. Reoperative Crohn’s surgery: Tricks of the trade. Clin Colon Rectal Surg. 2007;20(4):336–343. doi:10.1055/s-2007-991034
  74. Tajra JBM, Calegaro JU, Silva SME, et al. Assessment of risk factors for surgery treatment of Crohn’s disease: A hospital cohort. Arq Bras Cir Dig. 2023;36:e1730. doi:10.1590/0102-672020230002e1730
  75. Lin SN, Zheng DP, Qiu Y, et al. Classifying Crohn’s disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification. Ther Adv Gastroenterol. 2020;13:1756284820968732. doi:10.1177/1756284820968732
  76. Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: A systematic review. Gut. 2013;62(7):1072–1084. doi:10.1136/gutjnl-2012-304353
  77. Sinopoulou V, Gordon M, Akobeng AK, et al. Interventions for the management of abdominal pain in Crohn’s disease and inflammatory bowel disease. Cochrane Database Syst Rev. 2021;2021(11):CD013531. doi:10.1002/14651858.CD013531.pub2
  78. Seifarth C, Kreis ME, Gröne J. Indications and specific surgical techniques in Crohn’s disease. Visc Med. 2015;31(4):273–279. doi:10.1159/000438955
  79. Bechara CDS, Lacerda Filho A, Ferrari MDLA, Andrade DAR, Luz MMPD, Silva RGD. Montreal classification of patient operated for Crohn’s disease and identification of surgical recurrence predictors. Rev Col Bras Cir. 2015;42(2):97–104. doi:10.1590/0100-69912015002006
  80. Martínez Sánchez ER, Solá Fernández A, Pérez Palacios D, et al. Perianal Crohn’s disease: Clinical implications, prognosis and use of resources. Rev Esp Enferm Dig. 2021;114(5):254–258. doi:10.17235/reed.2021.7918/2021